Next Article in Journal
Toxic Effects of Domoic Acid in the Seabream Sparus aurata
Previous Article in Journal
Immense Essence of Excellence: Marine Microbial Bioactive Compounds
Previous Article in Special Issue
Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2010, 8(10), 2702-2720; doi:10.3390/md8102702

Marine Antitumor Drugs: Status, Shortfalls and Strategies

1
Department of Chemistry, Pukyong National University, Busan 608-737, Korea
2
Marine Bioprocess Research Center, Pukyong National University, Busan 608-737, Korea
*
Author to whom correspondence should be addressed.
Received: 31 August 2010 / Revised: 17 September 2010 / Accepted: 13 October 2010 / Published: 15 October 2010
(This article belongs to the Special Issue Marine Drugs as Antitumour Agents)
View Full-Text   |   Download PDF [493 KB, uploaded 24 February 2015]   |  

Abstract

Cancer is considered as one of the deadliest diseases in the medical field. Apart from the preventive therapies, it is important to find a curative measure which holds no loopholes and acts accurately and precisely to curb cancer. Over the past few decades, there have been advances in this field and there are many antitumor compounds available on the market, which are of natural as well as synthetic origin. Marine chemotherapy is well recognized nowadays and profound development has been achieved by researchers to deal with different molecular pathways of tumors. However, the marine environment has been less explored for the production of safe and novel antitumor compounds. The reason is a number of shortfalls in this field. Though ample reviews cover the importance and applications of various anticancerous compounds from marine natural products, in the present review, we have tried to bring the current status of antitumor research based on marine inhibitors of cancer signaling pathways. In addition, focus has been placed on the shortfalls and probable strategies in the arena of marine antitumor drug discovery. View Full-Text
Keywords: marine antitumor compounds; cancer signaling pathways; shortfalls in cancer research; clinical status of antitumor drugs marine antitumor compounds; cancer signaling pathways; shortfalls in cancer research; clinical status of antitumor drugs
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Bhatnagar, I.; Kim, S.-K. Marine Antitumor Drugs: Status, Shortfalls and Strategies. Mar. Drugs 2010, 8, 2702-2720.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top